A continuous-flow assay for measuring oxalate in urine is described. Covalently attached oxalate oxidase (EC 1.2.3.4) is used to oxidise the oxalate anion to carbon dioxide and hydrogen peroxide. The formed hydrogen peroxide is measured colorimetrically (A,RlJ) with an established reaction using horseradish peroxidase (EC 1.11.17), 3-methyl-2-benzothiazolinone hydrazone (MBTH) and 3-dimethylaminobenzoic acid (DMAB). Ascorbate interference is eliminated by treating the urine sample with sodium nitrite prior to assaying. The assay is accurate (mean recovery of added oxalate in spiked urine sample is 93±1l%), sensitive (detection limit 1·0 ILmoUL), reproducible (within-batch CV 3·5%; between-batch CV 5%) and relatively rapid (15 samples/h). This assay correlates well (R=0'99) with another established enzymatic method (using oxalate decarboxylase).
A number of analytical procedures for the estimation of urinary oxalate have been developed and several reviews on these methods have been published. 1-3 Most of these methods are prone to error (see below), time consuming and require tedious sample pretreatment. The need for a simple and accurate assay capable of handling a large number of samples still remains.
One special problem which we noticed in our laboratory arises from urinary i.-ascorbate. Ascorbate can interfere with oxalate assays in two ways. First, in methods using oxalate oxidase and generation of H 2 0 2 the ascorbate can be oxidised to de hydroascorbate by the H 2 0 2 generated which therefore becomes unavailable for colour development. Second, it has been known since 1933 4 that under alkaline conditions L-ascorbate can be converted to oxalate as shown below.
We have confirmed' that the generation of oxalate from L-ascorbate increases with increasing pH and this conversion is further enhanced in the presence of activated charcoal as previously reported.?: 7 Here we describe a rapid, precise and automated procedure for measuring urinary oxalate. It avoids alkaline conditions, and a simple pretreatment procedure with sodium nitrite eliminates the interference by L-ascorbate presumably by catalysing conversion to dehydroascorbate." Samples containing normal levels of urinary oxalate are diluted 1:50 which reduces interference by other urinary constituents. Oxalate in nitrite-treated and diluted sample is oxidised by immobilised oxalate oxidase (EC 1. 2.3.4) to hydrogen peroxide and carbon dioxide. The formed H 2 0 2 is quantitated by the increase in absorbance at 580 nm directly resulting from the formation of an indamine dye produced by the peroxidase (EC 1.11.17)-catalysed oxidative coupling of 3-methyl-2-benzothiazolinone hydrazone (MBTH) and 3-dimethylaminobenzoic acid (DMAB). 
REAGENTS
Stock citrate buffer pH 3·5; 0·25 mol/L This reagent was prepared by dissolving 30·5 g tri-potassium citrate; 50·0 g citric acid and 2·0 g disodium EDTA in 1 litre of double de ionised water and stored at 4°C.
Working citrate buffer pH 3·5; 0·05 mol/L The working citrate buffer pH 3·5; 0·05 rnol/L was prepared daily by diluting the above stock buffer 1:5 with deionised water.
Standard oxalate solution (20 mmol/L)
A stock standard oxalate solution was prepared by dissolving 252 mg oxalic acid dihydrate in 100 mL of 0·1 mollL HCl and stored at 4°C.
Working standard oxalate solutions of 0·1, 0·2, and 0·4 mmol/L were prepared by diluting the above stock solution in 0·1 mol/L hydrochloric acid.
DMAB reagent (30·03 mmol/L)
This reagent was prepared by dissolving 100 mg DMAB solid in 5 rnl., 0·1 rnol/L HCl and then diluted to 20 mL with pH 3·5 (0,25 rnol/L) citrate buffer. This reagent is stable for 1 month when stored at 4°C.
MBTH reagent (21·5 mmol/L)
This reagent was prepared by dissolving 100 mg MBTH in 5 mL, 0·1 mollL HCl and then diluted to 20 mL with pH 3·5 (0,25 mol/L) citrate buffer. This reagent is stable for 1 month when stored at 4°C.
8-0H Quinoline reagent (68·9 mmol/L)
This reagent was prepared by dissolving 500 mg of powdered 8-hydroxyquinoline in 50 mL pH Automated assay for urinary oxalate 413 3·5 (0,05 mol/L) citrate buffer and stored at 4°C.
Final peroxidase colour reagent
The final colour reagent was prepared by adding 1 mL DMAB reagent, 0·5 mL MBTH reagent, 4 mg (400 units) peroxidase and then made up to 200 mL with pH 3·5, 0·05 mol/L citrate buffer.
8-0H Quinoline/wetting agent reagent
One millilitre 8-0H quinoline stock reagent and 100 JLL of Technicon Wetting Agent A, were added and mixed with 100 mL pH 3·5, 0·05 rnol/L citrate buffer.
Sodium nitrite (50 mmol/L) reagent
This reagent was prepared by dissolving 86·3 mg NaN0 2 in 25 mL pH 3·5, 0·05 rnol/L citrate buffer and it was used immediately or within a few hours. 
O-alkylation of nylon tubing
Five metres of nylon 6 tubing (Portex Hyde, UK) were filled with 0·1 mollL triethyloxonium tetrafluoroborate at room temperature for 20 min. The tubing was then purged with dichlororne thane previously dried with type 3A Molecular Sieve and aminated immediately.
Amination
The O-alkylated tubing was filled with 10% polyethyleneimine (PEl) in formamide and incubated for 2 h at room temperature. Excess PEl was removed by washing the tube thoroughly with ice-cold water.
Glutaraldehyde activation
The aminated tubing was perfused with 5% (w/v) glutaraldehyde in 0·1 mollL borate buffer (pH 8,5) for 15 min at room temperature at a flow rate of 2 ml/min. The tubing was then washed by perfusion with 0·15 mollL NaCI in borate buffer (0,2 rnol/L) for a further 20 min.
Enzyme immobilisation
The glutaraldehyde-activated tubing was filled with a solution of the enzyme (10 units) in 0·02 mol/L, pH 7·0 potassium phosphate. buffer , and containing 0·02 rnol/L KC1 then incubated overnight at 4°C. Excess protein and noncovalently bound protein were removed by perfusion with 0·05 mol/L pH 3·5 citrate buffer for 2 h at a flow rate of 2 rnl/rnin. The tubing with the bound enzyme was kept filled with the same buffer at 4°C and under the conditions described below showed no noticeable deterioration in activity of the bound enzyme over 9 months of use.
CONTINUOUS-FLOW SYSTEM
A redundant Technicon AAI system fitted with a Technicon recorder range expander was assembled as shown in Fig. 1 . Incorporation of the range expander within the system permitted a tenfold expansion of the signal from the colorimeter thus increasing the sensitivity of the assay. An AAI sampler operating at 30/h with a 1:2 sample-to-wash ratio was used in these studies. The diluted sample is passed through the nylon, oxalate oxidase-bearing coil kept in a water bath at 50°C. Oxalate in the sample is oxidised during transit through the coil to form hydrogen peroxide which is then determined enzymatically with horseradish peroxidase, MBTH and DMAB. The resulting indamine dye is determined colorimetrically at 580 nm. This colour reaction is more sensitive 10 than the colour reaction described by Barham and Trinder!' using 4-aminophenazone and dichlorophenol and is less susceptable to interference than other chromogenic systems for H 2 0 2 1U
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SAMPLE PREPARATION
One volume of freshly prepared sodium nitrite (50 mmol/L) is added to 10 volumes of oxalate standard or acidified (c. pH 2,0) urine samples and then vortex-mixed for 5-10 s. The nitritetreated samples are diluted 1:50 with pH 3·5, 0·05 mol/L citrate buffer and assayed immediately on the continuous-flow AAI system.
H URINE COLLECTIONS
Twenty-four hour urine samples were collected in 5 mL cone, HCI or with 1 mL of 50% (w/v) thymol in isopropanol. Samples which were collected in thymol were thoroughly mixed before 25 mL aliquots were removed and acidified to pH 2·0. Fifty-one samples used to obtain the normal range had also been used in a previous study':' and had been acidified and kept frozen between studies.
REFERENCE METHOD
The enzymatic method of Hallson and Rose!" using oxalate decarboxylase (EC 4.1.1.2) was used as a reference method in these studies. This method has been used routinely in these laboratories for over 12 years. Evaluation of the reference method both here 15 and independently elsewhere '" 17 have established its reliability for measuring urinary oxalate. Furthermore, this assay is not subject to interference from physiological levels of urinary Lascorbate. 
Results
Preliminary studies established that sodium nitrite removes L-ascorbate from aqueous solutions and from urine without simultaneously affecting the oxalate level (determined by both the reference and proposed methods) in the sample. Fig. 2 shows a typical recording from the proposed continuous-flow procedure and it illustrates the effect of sodium nitrite on Lascorbate and oxalate both in aqueous solutions Automated assay for urinary oxalate 415 and in urine. L-ascorbate at pH 3·5 bleaches the background colour in the peroxidase reagent which shows up as a 'dip' in the baseline on the recorder trace. Removal of the L-ascorbate with sodium nitrite eliminated the 'dip' in the baseline recording. Table 1 shows the recovery of added oxalate in 15 urine samples in which the oxalate levels were raised by 0·1, 0·2, and 0·4 mmol/L, Examination of Table 1 shows that by increasing the oxalate in urine samples by 0·1 mrnol/L yielded a mean recovery of 89% and this value improved to 95% at higher levels of added oxalate. The mean overall recovery of added oxalate was 93±11·9%. Table 2 shows the results obtained when five urine samples assayed neat and after dilution to 50% and 25% by the proposed procedure.
TEST FOR INTERFERENCE
In order to investigate whether certain substances could interfere with the assay the chemicals shown in Table 3 were processed and 1·0  100·0  20·0  10·0  5·0  500·0  500·0  5·0  5·0  1·0  500·0  10·0  5·0 giL  5·0  5·0  5·0  5·0  5·0  5·0  5·0  10·0  5·0  10·0  20·0 5·0 5·0 5·0 2·4 excretion in 61 normal subjects (38 males and 23 females: age 18--63) on unrestricted diets. The mean and standard deviation of the 24 h oxalate excretion is 0·24±0·09 mmol/24h (range 0·06-0·42) with no significant sex-related difference.
Discussion
As mentioned above, previously described methods for assaying urinary oxalate are prone to errors, time consuming and require tedious sample pretreatment. Here the method described is a simple automated procedure that offers several distinct advantages. In some of the more recently published methods 1 i\-20 alkaline conditions have been used which would cause the generation of oxalate from L-ascorbate during sample pretreatment. Buttery et al. (1983) IX reported the generation of 1·3 mmol/L oxalate from 1·5 mmol/L aqueous L-ascorbate using their assay conditions which involve alkaline mixing of sample with charcoal. Similarly, when samples were processed by overnight incubation at pH 8·0 in ethanol and calcium sulphate, aqueous L-ascorbate generated oxalate.!? With the wide use of ascorbic acid as a dietary supplement to prevent various maladies such as common cold, atherosclerosis, cancer ,21 and also an antioxidant and stabiliser in foodstuffs it would be difficult to control the intake of this vitamin. Concentration of urinary ascorbate without dietary supplementation is expected to be 0'~'6 rnrnol/Lr" In a discrete automated oxalate assay'" published recently, the interference by L-ascorbate has been eliminated by acidic ferric chloride. This procedure uses soluble oxalate oxidase isolated from beet stems which has been claimed to have greater stability and resistance to inhibition by high salt concentration.j'' Oxalate oxidase from beet stem is not yet available commercially. The assay described by Obzansky and Richardsorr'" requires an additional cation-exchange resin step to remove ferric ions and other urinary enzyme inhibitors. In the assay proposed here, ascorbate interference up to a cone, of 10 mmollL (1760 mg/L) did not show any interference.
Here covalently attached oxalate oxidase (commercial preparation) is used and because it can be repeatedly re-used a considerable reduction in cost per assay results. So far over 1000 assays have been performed within 9 months using a single coil containing~10 units of oxalate oxidase. Assuming that the coil lasts for 1000 assays (and this can be expected given reasonable care), the cost per test of materials is as low as £0·10. This figure is lower than those of the previous routine assay using commercial oxalate decarboxylase (£3,25 per test), the Sigma manual procedure (£1·07 per test) and the Sigma procedure adapted to automation with the Centrifichem (£0·43 per test) or with Abbott VP (£0·27 per test) analysers.
The assay is specific and shows no interference from the 28 substances tested. In addition to these substances, immobilised oxalate oxidase has been shown to be unaffected by glyoxylate, ethylene glycol, carbonate, bicarbonate, lithium, pyruvate, NAD and NADH. 22 Preliminary studies confirmed that the immobilised enzyme is inhibited by salt, as is the enzyme in solution.P By increasing the sensitivity with a range expander, using 5 m of tubing containing immobilised oxalate oxidase and using 8-hydroxyquinoline as an oxalate oxidase activator, the sensitivity was such as to permit the dilution of urine by 1:50 with normal oxalate levels (0·05-{)·4 mmol/L), Urine samples from hyperoxalurics, with oxalate concentrations above 0·4 mrnol/L could be diluted even further.
Recoveries of oxalate added to urine were good (mean and SD=93±11·9%). Dilution of five urine samples of various concentrations by 50% and 25% before assaying (see Table 2 ) demonstrated that urinary constituents in these urines did not inhibit the immobilised oxalate oxidase. Urine samples which were not acidified before assaying yielded lower results with the proposed method when compared with the reference assay. This difference almost certainly arises from the fact that oxalate decarboxylase can decarboxylate crystalline and unionised calcium oxalate in the assay of Hallson and Rose '" whereas immobilised oxalate oxidase requires the oxalate to be ionised. The reference method!" using oxalate decarboxylase has been used in these laboratories for over 12 years. It has performed well during that time but unfortunately cannot be automated to cope with a large sample number. The proposed method offers the same reproducibility to the reference method but additionally can cope with a large number of samples with considerable saving in labour over the reference assay.
The performance of the assay as judged by the within-and between-batch variation was good (see Table 4 ). The normal range for urinary oxalate (0·Q6-..D·42 mmoV24 h) with mean excretion of O·24 mmoV24 h agrees closely with that of the reference method (mean and SD=0·30±0·08 mmoV24 h). No sex related differences in the '2.4 h oxalate excretion were seen in this study.
